Home
Research
Publications
Members
News
Contact
More
We are a translationally oriented research laboratory interested in answering significant questions on the treatment of the critically ill with particular emphasis on:
Hemodynamic stability
Proteolysis and Proteolytic Pathology
Inflammation
Did you catch our posters at APS 2024?
We presented at 2023 MHSRS and at the 46th Annual Shock Society Conference!
We presented at APS 2023!
Enteral administration of the protease inhibitor gabexate mesilate preserves vascular function in experimental trauma/hemorrhagic shock
Scientific Reports, 2023; 13: 10148.